Skip to main content
OpenTrials

Clinical trial condition

Unresectable Primary Peritoneal Serous Adenocarcinoma

Explore clinical trials studying Unresectable Primary Peritoneal Serous Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Unresectable Primary Peritoneal Serous Adenocarcinoma trial results

Completed

Olaparib and Onalespib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple-Negative Breast Cancer

NCT02898207

Conditions
Breast Diseases, Breast Neoplasms, Metastatic High Grade Fallopian Tube Serous Adenocarcinoma, +27 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View Trial Details

Related conditions